Keyphrases
United States
100%
Immunosuppression
100%
Post-transplant Lymphoproliferative Disorder
100%
Renal Transplantation
100%
Adjusted Hazard Ratio
80%
Mycophenolate
30%
Low Risk
20%
OKT3
20%
Pretransplant Malignancy
20%
Risk Factors
10%
Receptor Antagonist
10%
Young Age
10%
Induction Therapy
10%
Lymphoma
10%
Non-Hodgkin Lymphoma
10%
Old Age
10%
Cyclosporine
10%
Prognostic Factors
10%
Sirolimus
10%
Kidney Transplant Recipients
10%
Age-adjusted
10%
Patient History
10%
Mortality Factors
10%
Tacrolimus
10%
Poor Survival
10%
United States Renal Data System (USRDS)
10%
Antimetabolites
10%
Incidence Risk
10%
HLA Matching
10%
Medicaid Patients
10%
Medicine and Dentistry
Immunosuppressive Treatment
100%
Posttransplant Lymphoproliferative Disease
100%
Kidney Transplantation
100%
Hazard Ratio
80%
Mycophenolic Acid
30%
Cancer
20%
Azathioprine
20%
Receptor
10%
Medicare
10%
Non-Hodgkin Lymphoma
10%
Cyclosporine
10%
Prognostic Factor
10%
Tacrolimus
10%
Antimetabolite
10%
Rapamycin
10%
Pharmacology, Toxicology and Pharmaceutical Science
Posttransplant Lymphoproliferative Disease
100%
Mycophenolic Acid
30%
Azathioprine
20%
Receptor
10%
Medical History
10%
Nonhodgkin Lymphoma
10%
Rapamycin
10%
Ciclosporin
10%
Tacrolimus
10%
Antimetabolite
10%